YKL-40, also known as chitinase 3-like-1, and Krebs von den Lungen-6 (KL-6) are two promising biomarkers that may play an important role in the diagnosis and prognosis of patients with interstitial lung diseases. This evidence concerns the gene MUC1 and interstitial lung disease.